ALNYLAM PHARMACEUTICALS, INC.
ALNYLAM PHARMACEUTICALS, INC. (ALNY) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 1210 transactions totaling $2.5B, demonstrating a bullish sentiment with $1.5B in net insider flow. The most recent transaction on Jan 5, 2026 involved a transaction of 3,279 shares valued at $0.
ALNY Insider Activity Summary
Who Is Buying ALNY Stock?
No significant insider buying has been recorded for ALNY in the recent period.
Who Is Selling ALNY Stock?
No significant insider selling has been recorded for ALNY in the recent period.
Is ALNYLAM PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ALNY is bullish with an Insider Alignment Score of 80/100 and a net flow of $1.5B. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ALNY Frequently Asked Questions
Understanding ALNY Insider Activity
Insider trading at ALNYLAM PHARMACEUTICALS, INC. (ALNY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading ALNY stock, having executed 1210 transactions in the past 90 days. The most active insider is Sanofi (Executive), who has made 6 transactions totaling $2.0B.
Related Tools
Track ALNYLAM PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at ALNY file new Form 4 transactions